Author

A. V. Hill

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:mouse· 3 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

P. Dulal· 2 shared R. Ashfield· 2 shared A. A. Walters· 1 shared A. Banyard· 1 shared A. D. Douglas· 1 shared A. Douglas· 1 shared A. J. Ritchie· 1 shared A. Jainarayanan· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

P. Dulal

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Chemotherapy synergizes with cancer vaccines and expands stem-like TCF1+CD8+ T cells

L. Noblecourt, A. Wicki, V. Pereira-Almeida, J. McAuliffe, E. Steffke, S. Panetti, R. A. Ramirez-Valdez, V. Chandrasekar, A. Jainarayanan, A. V. Hill, B. J. Van den Eynde, C. S. K. Leung

This study shows that chemotherapy, specifically CarboTaxol, synergizes with cancer vaccines and anti-PD-1 to improve tumor control and survival by expanding stem-like TCF1+CD8+ T cells.

bioRxiv · Dec 18, 2023 · PreprintImmunology

The viral vectored vaccine targeting Thymosin β10 controls tumour growth in a murine model of prostate cancer

F. Cappuccini, J. Mueller, E. Pollock, A. V. Hill, N. Ternette, I. Redchenko

This study uses immunopeptidomic analysis to identify peptides overexpressed in murine prostate cancer and evaluates a viral vectored vaccine targeting Thymosin β10 for tumour growth control in a TRAMP model.

bioRxiv · Apr 6, 2021 · PreprintImmunology

Characterisation of factors contributing to the performance of nonwoven fibrous matrices as substrates for adenovirus vectored vaccine stabilisation

P. Dulal, A. A. Walters, N. Hawkins, T. D. Claridge, K. Kowal, S. Neill, S. J. Russell, A. J. Ritchie, R. Ashfield, A. V. Hill, A. D. Douglas

The paper investigates fibrous matrices for adenovirus vaccine stabilisation, identifies polyvinyl alcohol as a key stabilising component, and develops a custom matrix for clinical translation.

bioRxiv · Jan 31, 2020Pharmacology & Toxicology

A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis

C. Wang, P. Dulal, X. Zhou, Z. Xiang, H. Goharriz, A. Banyard, N. Green, L. Brunner, R. Ventura, N. Collin, S. J. Draper, A. V. Hill, R. Ashfield, A. R. Fooks, H. C. Ertl, A. Douglas

This paper develops a simian-adenovirus-vectored rabies vaccine that can be thermostabilized and administered as a single dose, showing potent immunogenicity and potential for low-cost pre-exposure prophylaxis.

bioRxiv · Sep 4, 2018Immunology